Mark Harnett

751 total citations
27 papers, 545 citations indexed

About

Mark Harnett is a scholar working on Molecular Biology, Small Animals and Surgery. According to data from OpenAlex, Mark Harnett has authored 27 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Small Animals and 5 papers in Surgery. Recurrent topics in Mark Harnett's work include Veterinary Pharmacology and Anesthesia (6 papers), Anesthesia and Pain Management (4 papers) and Anesthesia and Sedative Agents (4 papers). Mark Harnett is often cited by papers focused on Veterinary Pharmacology and Anesthesia (6 papers), Anesthesia and Pain Management (4 papers) and Anesthesia and Sedative Agents (4 papers). Mark Harnett collaborates with scholars based in United States, United Kingdom and Spain. Mark Harnett's co-authors include David Staskin, Scott A. Reines, LuAnn Sabounjian, Bobby W. Sandage, Christina Wang, Adrian S. Dobs, Ronald S. Swerdloff, Nicholas Silver, David E. Elliott and S. B. Hanauer and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Mark Harnett

26 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Harnett United States 13 135 121 117 108 90 27 545
Alessandro Rossi Italy 18 238 1.8× 158 1.3× 10 0.1× 263 2.4× 134 1.5× 78 1.1k
Geneviève Lachance United Kingdom 11 263 1.9× 32 0.3× 14 0.1× 35 0.3× 78 0.9× 13 767
Shahab Ahmadzadeh United States 13 89 0.7× 35 0.3× 13 0.1× 31 0.3× 20 0.2× 125 576
Brian N. Nightingale Australia 14 110 0.8× 324 2.7× 11 0.1× 25 0.2× 71 0.8× 20 631
Paolo Baroldi Italy 12 49 0.4× 55 0.5× 38 0.3× 17 0.2× 5 0.1× 23 733
Shoshannah Beck Australia 5 400 3.0× 70 0.6× 16 0.1× 12 0.1× 42 0.5× 8 732
Walidah Walker United States 8 145 1.1× 26 0.2× 31 0.3× 19 0.2× 52 0.6× 9 1.2k
T Fait Czechia 13 77 0.6× 39 0.3× 14 0.1× 34 0.3× 126 1.4× 76 657
Mariano Sust Spain 13 152 1.1× 42 0.3× 26 0.2× 23 0.2× 7 0.1× 31 519
Xujun Yu China 10 69 0.5× 14 0.1× 59 0.5× 19 0.2× 17 0.2× 53 345

Countries citing papers authored by Mark Harnett

Since Specialization
Citations

This map shows the geographic impact of Mark Harnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Harnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Harnett more than expected).

Fields of papers citing papers by Mark Harnett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Harnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Harnett. The network helps show where Mark Harnett may publish in the future.

Co-authorship network of co-authors of Mark Harnett

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Harnett. A scholar is included among the top collaborators of Mark Harnett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Harnett. Mark Harnett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berry‐Kravis, Elizabeth, et al.. (2024). Auditory N1 event-related potential amplitude is predictive of serum concentration of BPN14770 in fragile X syndrome. Molecular Autism. 15(1). 47–47. 2 indexed citations
2.
3.
Berry‐Kravis, Elizabeth, et al.. (2021). Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial. Nature Medicine. 27(5). 862–870. 85 indexed citations
4.
Chen, Michael C., et al.. (2021). A Randomized Phase 1 Evaluation of Deupirfenidone, a Novel Deuterium‐Containing Drug Candidate for Interstitial Lung Disease and Other Inflammatory and Fibrotic Diseases. Clinical Pharmacology in Drug Development. 11(2). 220–234. 10 indexed citations
5.
Valent, Jason, Jeffrey A. Zonder, Michaela Liedtke, et al.. (2021). Safety and Tolerability of Cael-101 in Combination with Anti-Plasma Cell Dyscrasia Therapy in Patients with AL Amyloidosis: 1-Year Results from an Open-Label Phase 2 Trial. Blood. 138(Supplement 1). 468–468. 1 indexed citations
6.
Valent, Jason, Michael R. Kurman, Mark Harnett, et al.. (2021). Updated Organ Response Results of an Open-Label Study to Evaluate the Safety and Tolerability of Cael-101 in Patients with AL Amyloidosis Receiving Anti-Plasma Cell Therapy. Blood. 138(Supplement 1). 2724–2724. 2 indexed citations
7.
Minkowitz, Harold S., David Leiman, Lucy Lu, et al.. (2020). <p>IV Tramadol – A New Treatment Option for Management of Post-Operative Pain in the US: An Open-Label, Single-Arm, Safety Trial Including Various Types of Surgery</p>. Journal of Pain Research. Volume 13. 1155–1162. 5 indexed citations
8.
Minkowitz, Harold S., David Leiman, Daneshvari R. Solanki, et al.. (2020). Intravenous Tramadol is Effective in the Management of Postoperative Pain Following Abdominoplasty: A Three-Arm Randomized Placebo- and Active-Controlled Trial. Drugs in R&D. 20(3). 225–236. 13 indexed citations
9.
Lu, Lucy, Mark Harnett, & Scott A. Reines. (2020). IV tramadol: A novel option for US patients with acute pain—A review of its pharmacokinetics, abuse potential and clinical safety record. Journal of Opioid Management. 16(4). 297–306. 3 indexed citations
10.
Singla, Neil, Richard Pollak, David Leiman, et al.. (2020). Efficacy and Safety of Intravenously Administered Tramadol in Patients with Moderate to Severe Pain Following Bunionectomy: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study. SHILAP Revista de lepidopterología. 9(2). 545–562. 12 indexed citations
11.
Reines, Scott A., et al.. (2020). Misuse of Tramadol in the United States: An Analysis of the National Survey of Drug Use and Health 2002-2017. Substance Abuse Research and Treatment. 14. 622487510–622487510. 31 indexed citations
12.
Lang, Frederick, et al.. (2019). The natural history of Type 1 infantile GM1 gangliosidosis: A literature-based meta-analysis. Molecular Genetics and Metabolism. 129(3). 228–235. 19 indexed citations
13.
Lu, Lucy, Michael Ryan, Mark Harnett, George Atiee, & Scott A. Reines. (2019). Comparing the Pharmacokinetics of 2 Novel Intravenous Tramadol Dosing Regimens to Oral Tramadol: A Randomized 3‐Arm Crossover Study. Clinical Pharmacology in Drug Development. 9(4). 537–546. 8 indexed citations
14.
Braman, Virginia, Philip B. Graham, Changfu Cheng, et al.. (2013). A Randomized Phase I Evaluation of CTP‐499, a Novel Deuterium‐Containing Drug Candidate for Diabetic Nephropathy. Clinical Pharmacology in Drug Development. 2(1). 53–66. 27 indexed citations
15.
16.
Wang, Christina, Mark Harnett, Adrian S. Dobs, & Ronald S. Swerdloff. (2010). Pharmacokinetics and Safety of Long‐Acting Testosterone Undecanoate Injections in Hypogonadal Men: An 84‐Week Phase III Clinical Trial. Journal of Andrology. 31(5). 457–465. 51 indexed citations
17.
Sandage, Bobby W., et al.. (2009). Pharmacokinetics of Once‐Daily Trospium Chloride 60 mg Extended Release and Twice‐Daily Trospium Chloride 20 mg in Healthy Adults. The Journal of Clinical Pharmacology. 50(2). 143–150. 11 indexed citations
18.
Sandage, Bobby W., LuAnn Sabounjian, James E. Shipley, et al.. (2006). Predictive Power of an In Vitro System to Assess Drug Interactions of an Antimuscarinic Medication: A Comparison of In Vitro and In Vivo Drug‐Drug Interaction Studies of Trospium Chloride With Digoxin. The Journal of Clinical Pharmacology. 46(7). 776–784. 15 indexed citations
19.
Zinner, Norman R., Mark Harnett, LuAnn Sabounjian, et al.. (2005). THE OVERACTIVE BLADDER-SYMPTOM COMPOSITE SCORE: A COMPOSITE SYMPTOM SCORE OF TOILET VOIDS, URGENCY SEVERITY AND URGE URINARY INCONTINENCE IN PATIENTS WITH OVERACTIVE BLADDER. The Journal of Urology. 173(5). 1639–1643. 54 indexed citations
20.
Staskin, David & Mark Harnett. (2004). Effect of trospium chloride on somnolence and sleepiness in patients with overactive bladder. Current Urology Reports. 5(6). 423–426. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandro Rossi Breakdown of academic impact, for papers by Geneviève Lachance Breakdown of academic impact, for papers by Shahab Ahmadzadeh Breakdown of academic impact, for papers by Brian N. Nightingale Breakdown of academic impact, for papers by Paolo Baroldi Breakdown of academic impact, for papers by Shoshannah Beck Breakdown of academic impact, for papers by Walidah Walker Breakdown of academic impact, for papers by T Fait Breakdown of academic impact, for papers by Mariano Sust Breakdown of academic impact, for papers by Xujun Yu
Rankless by CCL
2026